Publications by Lars Magne Eri
63 publications found
Original articles
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
Eur Urol Open Sci, 45, 68-75
DOI 10.1016/j.euros.2022.09.002, PubMed 36353660
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
Scand J Urol, 55 (4), 287-292
DOI 10.1080/21681805.2021.1946135, PubMed 34196594
Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique
Scand J Urol, 53 (6), 385-391
DOI 10.1080/21681805.2019.1693625, PubMed 31797716
Role of serum response factor expression in prostate cancer biochemical recurrence
Prostate, 78 (10), 724-730
DOI 10.1002/pros.23516, PubMed 29608018
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 118 (6), e11
DOI 10.1038/bjc.2017.470, PubMed 29462127
Switching from laparoscopic radical prostatectomy to robot assisted laparoscopic prostatectomy: comparing oncological outcomes and complications
Scand J Urol, 52 (2), 116-121
DOI 10.1080/21681805.2017.1420099, PubMed 29334304
[Not Available]
Tidsskr Nor Laegeforen, 137 (22)
DOI 10.4045/tidsskr.17.0710, PubMed 29181947
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 117 (11), 1656-1664
DOI 10.1038/bjc.2017.346, PubMed 28972967
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
J Alzheimers Dis, 55 (1), 371-379
DOI 10.3233/JAD-160461, PubMed 27662296
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859
PBX3 is a putative biomarker of aggressive prostate cancer
Int J Cancer, 139 (8), 1810-20
DOI 10.1002/ijc.30220, PubMed 27273830
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
Scand J Urol, 50 (4), 280-5
DOI 10.3109/21681805.2016.1163617, PubMed 27049891
[Not Available]
Prog Urol, 25 (13), 832-3
DOI 10.1016/j.purol.2015.08.231, PubMed 26544425
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
Eur Urol, 69 (1), 149-56
DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143
Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
Eur Urol, 68 (3), 487-96
DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692
Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report
Open Microbiol J, 8, 148-53
DOI 10.2174/1874285801408010148, PubMed 25685246
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
BJU Int, 114 (6b), E32-E42
DOI 10.1111/bju.12637, PubMed 24447606
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766
A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up
Urology, 81 (4), 781-6
DOI 10.1016/j.urology.2013.01.017, PubMed 23465150
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630
Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
BJU Int, 109 (9), 1366-74
DOI 10.1111/j.1464-410X.2011.10598.x, PubMed 21999333
Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer
Scand J Urol Nephrol, 46 (1), 8-13
DOI 10.3109/00365599.2011.604790, PubMed 21843041
Accuracy and repeatability of prostate volume measurements by transrectal ultrasound
Prostate Cancer Prostatic Dis, 5 (4), 273-8
DOI 10.1038/sj.pcan.4500568, PubMed 12627211
Comparative study of pressure-flow parameters
Neurourol Urodyn, 21 (3), 186-93
DOI 10.1002/nau.10018, PubMed 11948710
The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery
World J Urol, 19 (4), 256-8
DOI 10.1007/s003450000180, PubMed 11550784
Test-retest variation of pressure flow parameters in men with bladder outlet obstruction
J Urol, 165 (4), 1188-92
DOI 10.1016/S0022-5347(05)66466-X, PubMed 11257668
The effect of bicalutamide on prostate histology
Prostate, 46 (4), 275-80
DOI 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>3.0.co;2-2, PubMed 11241549
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)
Prostate Cancer Prostatic Dis, 4 (3), 173-177
DOI 10.1038/sj.pcan.4500504, PubMed 12497037
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Urology, 56 (2), 261-5
DOI 10.1016/s0090-4295(00)00629-4, PubMed 10925090
Bladder and sexual dysfunction after mesorectal excision for rectal cancer
Br J Surg, 87 (2), 206-10
DOI 10.1046/j.1365-2168.2000.01357.x, PubMed 10671929
[Timely screening routines for prostatic cancer by Norwegian physicians]
Tidsskr Nor Laegeforen, 119 (24), 3572-6
PubMed 10563174
[Diagnosis and treatment of benign prostatic hyperplasia in general practice. Norwegian Medical Society]
Tidsskr Nor Laegeforen, 116 (27), 3240-4
PubMed 9011979
Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia
Scand J Clin Lab Invest, 56 (4), 319-25
DOI 10.3109/00365519609090583, PubMed 8837238
Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome
Scand J Urol Nephrol Suppl, 179, 113-7
PubMed 8908676
Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia
J Urol, 154 (1), 100-4
DOI 10.1016/S0022-5347(01)67239-2, PubMed 7539852
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia
Br J Urol, 75 (3), 335-40
DOI 10.1111/j.1464-410x.1995.tb07345.x, PubMed 7537602
Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia
Scand J Urol Nephrol Suppl, 172, 95-8
PubMed 8578262
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia
Eur Urol, 27 (4), 274-9
DOI 10.1159/000475180, PubMed 7544732
Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia
J Urol, 152 (2 Pt 1), 448-52
DOI 10.1016/s0022-5347(17)32760-x, PubMed 7516978
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia
Eur Urol, 26 (3), 219-26
DOI 10.1159/000475384, PubMed 7528662
A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia
J Urol, 150 (2 Pt 1), 359-64
DOI 10.1016/s0022-5347(17)35483-6, PubMed 7686981
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia
J Urol, 150 (1), 90-4
DOI 10.1016/s0022-5347(17)35406-x, PubMed 7685428
Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients
Eur Urol, 21 (4), 257-62
DOI 10.1159/000474853, PubMed 1281101
Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia
Eur Urol, 22 (1), 9-13
DOI 10.1159/000474714, PubMed 1385147
Pseudocyst of the spleen after closed abdominal injury
Injury, 19 (4), 297
DOI 10.1016/0020-1383(88)90057-5, PubMed 3229854
[Primary megaureter in adults]
Tidsskr Nor Laegeforen, 108 (12), 930-2
PubMed 3381207
[Urethral diverticulum in women]
Tidsskr Nor Laegeforen, 108 (12), 925-7
PubMed 3132747
[Erectile impotence and disorders of venous circulation]
Tidsskr Nor Laegeforen, 108 (8-9), 679-80
PubMed 3353971
[Congenital curvature of the erect penis without simultaneous changes in the urethra or corpus spongiosum and with normal erection]
Tidsskr Nor Laegeforen, 108 (8-9), 683-5
PubMed 3353973
Abnormal venous drainage from the penis examined by dynamic cavernosography and surgically treated
Scand J Urol Nephrol Suppl, 110, 261-5
PubMed 3187421
[Surgical treatment of the impingement syndrome]
Tidsskr Nor Laegeforen, 107 (6), 543-4
PubMed 3576543
[Subtotal cholecystectomy. An alternative to a difficult cholecystectomy]
Tidsskr Nor Laegeforen, 107 (5), 467-8
PubMed 3576533
[Acute total dislocation of the acromioclavicular joint. Surgical treatment]
Tidsskr Nor Laegeforen, 106 (30), 2515-7, 2530
PubMed 3798429
[Primary hyperparathyroidism. Surgical case material from Aker Hospital 1974-85]
Tidsskr Nor Laegeforen, 106 (12), 1028-30
PubMed 3726830
[Preoperative localization of parathyroid tumors. CT and ultrasonics before surgery of primary hyperparathyroidism]
Tidsskr Nor Laegeforen, 106 (12), 1042-5
PubMed 3523823
[Adenocarcinoma of the colon and rectum. A population study]
Tidsskr Nor Laegeforen, 105 (9-10), 665-8
PubMed 3992555
[Percutaneous transluminal angioplasty in the lower limbs]
Tidsskr Nor Laegeforen, 105 (7), 503-6
PubMed 3158096
[Inguinal hernia in children. Case material from a central hospital]
Tidsskr Nor Laegeforen, 104 (2), 81-3
PubMed 6701841
Review articles
No randomised trial of prostate-cancer screening in Norway
Lancet Oncol, 2 (12), 741-5; discussion 746-9
DOI 10.1016/S1470-2045(01)00588-5, PubMed 11902516
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective
Drugs Aging, 10 (2), 107-18
DOI 10.2165/00002512-199710020-00004, PubMed 9061268
alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia
J Urol, 154 (3), 923-34
DOI 10.1016/S0022-5347(01)66936-2, PubMed 7543612
Other articles
[Re: Implementation of guidelines for PSA testing in general practice]
Tidsskr Nor Laegeforen, 135 (1), 15
DOI 10.4045/tidsskr.14.1494, PubMed 25589118
Book chapters
Prostatakreft: feilinformasjon og begrepsforvirring
In Dagens medisin, Dagens medisin, Oslo, (2003)7, s.Kronikk og debatt
BIBSYS 041704622